Your prediction
Sartorius Stedim Biotech S.A. Stock
The price for the Sartorius Stedim Biotech S.A. stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.190%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Sartorius Stedim Biotech S.A. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Sartorius Stedim Biotech S.A. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sartorius Stedim Biotech S.A. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sartorius Stedim Biotech S.A. | -0.190% | 2.747% | 9.840% | 21.171% | 16.027% | -36.661% | -27.285% |
| bioMerieux S.A. | 0.000% | -2.330% | -2.873% | 7.487% | 1.846% | 7.531% | -10.580% |
| EssilorLuxottica SA | -1.710% | -3.528% | -5.992% | 28.658% | 27.230% | 69.231% | 134.724% |
| Dexcom Inc. | 0.430% | 2.608% | 9.010% | -24.574% | -25.483% | -49.406% | -21.616% |
Comments
Sartorius Stedim Biotech S.A. (OTCMKTS: SDMHF) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Show more
Ratings data for SDMHF provided by MarketBeat
News
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025



